Evolent Health, Inc. EVH
NYSE · XNYS · stock · Services-Management Services · website · IPO 2015-06-05
Evolent Health, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -21.9% | -1.6% | -3.6% | 0.3% | -4.7% |
| Net margin | -28.5% | -2.4% | -5.8% | -1.4% | -4.1% |
| Return on assets | -28.1% | -2.4% | -4.2% | -1.1% | -2.6% |
| Return on equity | -128.7% | -6.2% | -10.6% | -2.2% | -5.4% |
| Debt / equity | 2.34× | 0.49× | 0.56× | 0.48× | 0.31× |
| Current ratio | 1.31 | 0.85 | 1.01 | 1.10 | 1.18 |
| Revenue growth | -26.6% | 30.1% | 45.3% | 48.9% | -1.8% |
Source: SEC EDGAR filings · CIK 0001628908 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.